DrugAug 6, 2025
Bicillin L-A recall — FDA D-0544-2025
CGMP Deviations; particulates identified during visual inspection
Class IIFDA: OngoingPfizer Inc.
Recall history in this database
Classification mix: Class II: 3.
DrugAug 6, 2025
Bicillin L-A recall — FDA D-0545-2025
CGMP Deviations; particulates identified during visual inspection
Class IIFDA: OngoingPfizer Inc.
DrugJul 2, 2025
DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of recall — FDA D-0489-2025
Discoloration; discolored solution from cracked vials
Class IIFDA: OngoingPfizer Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Pfizer Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.